Japan says drugmaker Gilead's COVID-19 treatment remdesivir now in use in hospitals

Reuters

14 May 2020 0 shares 1 views

Japan says drugmaker Gilead's COVID-19 treatment remdesivir now in use in hospitals

Reuters

Published 14 May 2020

Japan has begun treating severely ill COVID-19 patients with Gilead Sciences Inc's COVID-19 remdesivir drug, a health ministry official said, just days after giving the drug emergency approval as it seeks to curb the coronavirus outbreak.

Full Article

European, South Korean authorities vie for COVID-19 antiviral remdesivir

Reuters 29 May 2020

European and South Korean authorities are vying for Gilead Sciences' potential COVID-19 treatment, remdesivir, even though the..

Roche mixes Actemra with Gilead's remdesivir in COVID-19 trial
Reuters 28 May 2020
U.S. doctors call for remdesivir data to guide coronavirus treatment
Reuters 21 May 2020
Japan approves Gilead Sciences' remdesivir as COVID-19 drug
Reuters 07 May 2020
U.S. emergency approval broadens use of Gilead's COVID-19 drug remdesivir
Reuters 01 May 2020

More coverage

FDA authorizes emergency use of Gilead's COVID-19 drug remdesivir

Gilead Science Inc's antiviral drug remdesivir was granted emergency use authorization by the U.S. Food and Drug Administration for..

Reuters 01 May 2020

FDA authorizes remdesivir drug as emergency treatment for COVID-19

The U.S. Food and Drug Administration (FDA) has granted authorization to Gilead Sciences Inc for emergency use of its experimental..

Reuters 01 May 2020

Japan says drugmaker Gilead's COVID-19 treatment remdesivir now in use in hospitals

Japan says drugmaker Gilead's COVID-19 treatment remdesivir now in use in hospitals

You might like

Related news coverage

European, South Korean authorities vie for COVID-19 antiviral remdesivir

Advertisement

More coverage

FDA authorizes emergency use of Gilead's COVID-19 drug remdesivir

FDA authorizes remdesivir drug as emergency treatment for COVID-19